Dyslipidemia and mean lipid profile in patients with liver cirrhosis

Sajjad Sohail, Muhammad Imran Mustafa, Mohammad Arif Shaheen, Qazi Masroor Ali, Mohammad Sohail Tariq


Background: Patients with liver disorders are often found to have deranged lipid profile. Clear decline is observed in the levels of cholesterol as well as TG among individuals having severe hepatitis and liver failure as synthesis of lipoprotein is reduced. This study was done to determine the frequency of dyslipidemia and the mean lipid profile values in patients of liver cirrhosis.

Methods: A cross sectional, descriptive study, done at the Department of Medicine, Medical Unit-1, Bahawal Victoria Hospital, Bahawalpur, from July to December 2019. A total of 246 patients presented with cirrhosis of liver of age 20-60 years and both genders were included. Analysis for serum total cholesterol (TC) level, serum triglycerides level, low density lipoprotein (LDL) and high density lipoprotein (HDL) were done and findings were noted.

Results: Mean age was 51.67±6.21 years. Out of the 246 patients, 153 (62.20%) were male and 93 (37.80%) were females with male to female ratio of 1.6:1. Mean values of lipid were, LDL cholesterol 95.76±29.65 mg/dl, HDL 43.37±11.46 mg/dl, TC 147.51±42.69 mg/dl and TG 101.29±21.59 mg/dl. Dyslipidemia was found in 59 (23.98%) patients, whereas there was no dyslipidemia in 187 (76.02%) patients.

Conclusions: Frequency of dyslipidemia in cirrhotic patients is high. Evaluating patients of liver cirrhosis, dyslipidemia need to be considered for early recognition and analysis.


Cholesterol, Cirrhosis, Lipoprotein, Triglycerides

Full Text:



Yoo HJ, Jung KJ, Kim M, Kim M, Kang M, Jee SH, et al. Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls. Front. Physiol. 2019;10:1421.

Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-71.

Powell EE, Skoien R, Rahman T, Clark PJ, O’Beirne J, Hartel G, et al. Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians. EClinicalMedicine 2019;11(2019):44-53.

Ullah F, Khan S, Afridi AK. Frequency of different Causes of Cirrhosis Liver in local population. Gomal J Med Sci. 2012;10(2):178-81.

Asrani SK, Kouznetsova M, Ogola G, Taylor T, Masica A, Pope B, et al. Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004-2013. Gastroenterology 2018;155(3):719-29

Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore) 2016;95(8):e2877.

Ghadir MR, Riahin AA, Havasupai A, Nooranipour M, Habibinejad AA. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat Mon 2010;10(4):285-8.

Miller JP. Dyslipoproteinaemia of liver diseases. Baillieres Clin Endocrinol Metab. 1990;4:807-32.

Mandal SK, Sil K, Chatterjee S, Ganguly J, Chatterjee K, Sarkar P, et al. A study on lipid profiles in chronic liver diseases. National J Med Res. 2013;3(1):70-2.

Nafees M, Abbas G, Saqib M. Validity of Ultrasound in Diagnosis of Liver Fibrosis Resulting from Chronic Viral Hepatitis. Pak J Armed Forces. 2011;61(4):585-89.

EL-Kabbany ZA, Hamza RT, Ibrahim SA, Mahmoud NH. Dyslipidemia and hyperinsulinemia in children and adolescents with chronic liver disease: relation to disease severity. Int J Adolesc Med Health 2013;2:1-7.

Shimizu H, Phuong V, Maia M, Kroh M, Chand B, Schauer PR, et al. Bariatric surgery in patients with liver cirrhosis. Surg Obesity Rela Dis. 2013;9(1):1-6.

Roesch DF, Pérez-Morales A, Melo-Santisteban G, Díaz-Blanco F, Martínez-Fernández S, Martínez JA, et al. [Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease]. Cir Cir. 2008;76(1):37-42.

Nayak MS, Shah RM. Study of lipid profile in cirrhotic patients. NJIRM. 2012;3(5):89-93.

Mehboob F, Ranjha FA, Masud S. Changes in Serum Lipid Profile among Patients Suffering From Chronic Liver Disease. Annals KEMU 2007;13(3):209.

Irfan S, Younas H, Ahmed W. Frequency of dyslipidemia and mean lipid profile in liver cirrhosis. Pak J Med Health Sci. 2014;8(3):786-88.

Breier C, Lisch HJ, Braunsteiner H. Lipoproteins, HDL apolopoproteins, activities of hepatic lipase and lecithincholesterol acyltransferase in the plasma of patients with postalcoholic end-stage liver cirrhosis. Klin Wochenschr. 1983;61(18):929-31.